ArticleCancer genomics & proteomics
LGALS3BP Links Centrosomes and Mitochondria to Maintain Energetic Fitness and Restrain Compensatory Lipid Catabolic Reprogramming in Hepatocellular Carcinoma.
Article in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimHepatocellular carcinoma (HCC) exhibits substantial metabolic plasticity that supports tumor progression and therapeutic resistance. LGALS3BP has been primarily characterized as a secreted immunomodulatory protein; however, its cell-intrinsic role in regulating subcellular organization and metabolism in HCC remains poorly understood. MATERIALS AND
methodsTranscriptomic analyses of public HCC cohorts were performed to assess metabolic programs associated with LGALS3BP expression. Proteomic profiling was conducted to define the LGALS3BP interactome. Mitochondrial function was evaluated by measuring adenosine triphosphate (ATP) levels, mitochondrial membrane potential (ΔΨm), and AMP-activated protein kinase (AMPK) activation. Lipid metabolic programs were assessed by gene expression analyses and lipid accumulation assays. Clinical relevance was independently validated in an institutional HCC cohort.
resultsLow LGALS3BP expression was associated with activation of peroxisome proliferator-activated receptor alpha (PPARα)-driven peroxisomal and lipid catabolic gene programs. Proteomic analyses revealed that LGALS3BP associates with centrosomal γ-tubulin ring complex components and mitochondrial proteins, suggesting a role in centrosome-mitochondria subcellular organization. Functionally, LGALS3BP deficiency resulted in impaired mitochondrial energetic fitness, reduced ATP production, and activation of AMPK. This energetic stress was accompanied by induction of PPARα and compensatory lipid catabolic transcriptional programs. Consistent inverse associations between LGALS3BP expression and PPARα-peroxisome-related genes, including PPARA, ACOX1, EPHX2, and SCP2, were observed across public HCC datasets and were independently validated in an institutional HCC patient cohort.
conclusionLGALS3BP acts as a cell-intrinsic organizer that links centrosomal architecture to mitochondrial energetic homeostasis in HCC. Loss of this organizational axis induces mitochondrial energetic stress and promotes compensatory PPARα-peroxisome-mediated lipid catabolic reprogramming, highlighting a previously unrecognized connection between subcellular organization and metabolic plasticity in liver cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.